Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma

Journal of Molecular Histology

Volumn 44, Issue 6, 2013, Pages 645-652

  Jin, Zhe ^a   Han, Ya Xin ^a   Han, Xiao Rui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chondrosarcoma; Clinicopathological parameters; Methylation; RUNX3

Indexed keywords

DNA; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CELL PROLIFERATION; CHONDROSARCOMA; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SARCOMA CELL; SURVIVAL TIME;

ADULT; AGED; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROSARCOMA; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR BURDEN;

EID: 84890559934     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9511-x     Document Type: Article

References (26)

1. Araki K, Osaki M, Nagahama Y, Hiramatsu T, Nakamura H, Ohgi S, Ito H (2005) Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis. Cancer Sci 96:227-231
2. Bai ZK, Guo B, Tian XC, Li DD, Wang ST, Cao H, Wang QY, Yue ZP (2013) Expression and regulation of Runx3 in mouse uterus during the peri-implantation period. J Mol Histol 2013 Apr 10 [Epub ahead of print]
3. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10:687-692
4. Bovee JV, Hogendoorn PC, Wunder JS, Alman BA (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 10:481-488
5. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC (2005) RUNX3 suppresses gastric epithelial cell growth by inducing p21 (WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25:8097-8107
6. Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV (2008) The clinical approach towards chondrosarcoma. Oncologist 13:320-329
7. Han YX, Liang DY (2011) The role of the tumor suppressor RUNX3 in giant cell tumor of the bone. Int J Oncol 40:673-678
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
9. Johnson S, Têtu B, Ayala AG, Chawla SP (1986) Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases. Cancer 58:278-286
10. Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH (2004) Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84:479-484
11. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG (2004) Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23:6736-6742
12. Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S (2006) RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 66:6512-6520
13. Lee CW, Chuang LS, Kimura S, Lai SK, Ong CW, Yan B, Salto-Tellez M, Choolani M, Ito Y (2011) RUNX3 functions as an oncogene in ovarian cancer. Gynecol Oncol 122:410-417
14. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y (1994) AML1, AML2, and AML3, the human members of the runt domain genefamily: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432
15. Li J, Kleeff J, Guweidhi A, Esposito I, Berberat PO, Giese T, Büchler MW, Friess H (2004a) RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol 57:294-299
16. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue KI, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y (2004b) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124
17. Lund AH, van Lohuizen M (2002) RUNX: a trilogy of cancer genes. Cancer Cell 1:213-215
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692
19. Rozeman LB, Cleton-Jansen AM, Hogendoorn PC (2006) Pathology of primary mailgnant bone and cartilage tumours. Int Orthop 30:437-444
20. Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M (2006) Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep 15:129-135
21. Wei D, Gong W, Oh SC, Li Q, Kim WD, Wang L, Le X, Yao J, Wu TT, Huang S, Xie K (2005) Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 65:4809-4816
22. Xiao WH, Liu WW (2004) Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 10:376-380
23. Yamamura Y, Lee WL, Inoue K, Ida H, Ito Y (2006) RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J Biol Chem 281:5267-5276
24. Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T (2007) Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer 58:131-138
25. York JE, Berk RH, Fuller GN, Rao JS, Abi-Said D, Wildrick DM, Gokaslan ZL (1999) Chondrosarcoma of the spine: 1954-1997. J Neurosurg 90:73-78
26. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61:249-255